Accutane Warnings

Systemic corticosteroids and phenytoin both have been added under the Drug Interactions musical organisation of Precautions and prescribers for pediatric patients are advised to use cautiousness with these drug combinations.
In suburbia, Roche recommends that patients receive Accutane at the recommended dose and no longer than the recommended period.
Under Contraindications and Warnings, a new furniture was added that identifies the need for pregnancy tests and accutane revision stickers for different case populations: men, women of child-bearing age, and women of non-child-bearing age.
For more selective information, healthcare professionals may striking Roche at 1-800-526-6367.
The full text of the revised trade name is available in PDF visual aspect on the FDA Web site at http://www.fda.gov/medwatch/SAFETY/2002/accutane_PI_6-02.pdf.
Reviewed by Gary D.
This is a part of article Accutane Warnings Taken from "Isotretinoin (Generic Accutane) Information" Information Blog